Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cyclo Therapeutics Inc (NQ: CYTH ) 1.210 +0.010 (+0.83%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 7,668 Open 1.200 Bid (Size) 1.210 (1) Ask (Size) 1.340 (7) Prev. Close 1.200 Today's Range 1.200 - 1.220 52wk Range 0.8924 - 2.124 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Cyclo Therapeutics to Present at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024 June 25, 2024 From Cyclo Therapeutics, Inc. Via Business Wire Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results June 14, 2024 Strategically focused on generating shareholder value by advancing our portfolio and identifying attractive investment opportunities with substantive upside potential From Rafael Holdings, Inc. Via GlobeNewswire Performance YTD -27.11% -27.11% 1 Month +0.83% +0.83% 3 Month -3.97% -3.97% 6 Month -28.82% -28.82% 1 Year -19.33% -19.33% More News Read More Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1 May 30, 2024 From Cyclo Therapeutics, Inc. Via Business Wire Cyclo Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update May 16, 2024 From Cyclo Therapeutics, Inc. Via Business Wire CYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q1 2024 May 16, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session April 18, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session April 02, 2024 Via Benzinga CYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q4 2023 March 19, 2024 Via InvestorPlace Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update March 18, 2024 From Cyclo Therapeutics, Inc. Via Business Wire Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease March 14, 2024 From Cyclo Therapeutics, Inc. Via Business Wire 12 Health Care Stocks Moving In Wednesday's After-Market Session March 13, 2024 Via Benzinga Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results March 13, 2024 From Rafael Holdings, Inc. Via GlobeNewswire Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office January 29, 2024 From Cyclo Therapeutics, Inc. Via Business Wire 12 Health Care Stocks Moving In Monday's Intraday Session January 15, 2024 Via Benzinga Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session December 28, 2023 Via Benzinga Why Bridgeline Digital Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket December 28, 2023 Via Benzinga Topics Earnings Exposures Financial 12 Health Care Stocks Moving In Wednesday's After-Market Session December 27, 2023 Via Benzinga Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc. December 27, 2023 From Cyclo Therapeutics, Inc. Via Business Wire Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1 December 18, 2023 From Cyclo Therapeutics, Inc. Via Business Wire Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results December 14, 2023 From Rafael Holdings, Inc. Via GlobeNewswire Cyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024 November 21, 2023 From Cyclo Therapeutics, Inc. Via Business Wire Cyclo Therapeutics Reports Third Quarter 2023 Financial Results November 15, 2023 From Cyclo Therapeutics, Inc. Via Business Wire 12 Health Care Stocks Moving In Wednesday's Intraday Session November 08, 2023 Via Benzinga Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results October 30, 2023 From Rafael Holdings, Inc. Via GlobeNewswire Cyclo Therapeutics Announces Early Exercise of Warrants by Board Members, Management and a Significant Shareholder Resulting in Cash Proceeds of $2.4 Million October 23, 2023 From Cyclo Therapeutics, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.